OSE Immunotherapeutics SA stock forecast
OSE Immunotherapeutics SA (ORPOF) Stock Forecast & Price Target
ORPOF Analyst Ratings
ORPOF Stock 12 Month Forecast
Detailed List of Analyst Forecasts
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Nicolas Pauillac | Kepler Capital | $9.10 | buy | 105.45%Upside | Reiterated | 04/30/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Nicolas PauillacKepler Capital | BuyReiterated$9.10 | 04/30/26 | 105.45%Upside |
Best Analysts Covering OSE Immunotherapeutics SA
Copying Nicolas Pauillac's trades and holding each position for 3 Months would result in 40.74% of your transactions generating a profit, with an average return of +2.27% per trade.
Copying Nicolas Pauillac's trades and holding each position for 1 Year would result in 40.74% of your transactions generating a profit, with an average return of +8.69% per trade.
Copying Nicolas Pauillac's trades and holding each position for 2 Years would result in 44.44% of your transactions generating a profit, with an average return of -19.92% per trade.
ORPOF Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 0 | 0 | 0 | 0 | 0 |
In the current month, ORPOF has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. ORPOF average Analyst price target in the past 3 months is ―.
ORPOF Financial Forecast
ORPOF Sales Forecast
Next quarter’s sales forecast for ORPOF is $0 with a range of ― to ―. The previous quarter’s sales results were $1.46M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
